Related Experiment Video
Updated: May 25, 2026
10:21
Protein Target Prediction and Validation of Small Molecule Compound
Published on: February 23, 2024
Specific noncovalent interactions at protein-ligand interface: implications for rational drug design
1Center of Bioinformatics (COBI), School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 610054, China. p_zhou@uestc.edu.cn
Current Medicinal Chemistry
|February 11, 2012
Summary
Medicinal chemists explore drug-target interactions using hydrogen bonds, halogen bonds, and salt bridges. Combining structural data and quantum mechanics offers new insights for rational drug design.
Area of Science:
- Structural Biology
- Computational Chemistry
- Medicinal Chemistry
- Drug Discovery
Background:
- Noncovalent interactions are crucial for drug-target binding.
- Advances in structural biology and computational power enable detailed analysis.
- Understanding these interactions aids in designing effective therapeutics.
Purpose of the Study:
- To review structural and theoretical studies of key noncovalent interactions.
- To investigate hydrogen bonds, halogen bonds, and salt bridges in protein-ligand complexes.
- To elucidate their role in molecular recognition and affinity.
Main Methods:
- Analysis of crystallographic data for protein-ligand complexes.
- Quantum-mechanical ab initio calculations.
- Integration of structural and computational approaches.
Main Results:
- Detailed characterization of geometrical and energetic properties of noncovalent interactions.
- Identification of hydrogen bonds, halogen bonds, and salt bridges as critical for binding.
- Demonstration of these forces' enthalpy-driven nature.
Conclusions:
- Specific noncovalent interactions significantly contribute to protein-ligand complex stability.
- Combined structural and computational methods provide deep insights into binding mechanisms.
- This knowledge is vital for advancing rational drug design strategies.
Related Concept Videos
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
01:25Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
02:04Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
02:04Protein-Protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
01:16Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...